POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.03A20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
2r3v MEVALONATE KINASE
(Homo
sapiens)
4 / 6ASN A 205
PHE A 190
ALA A 189
GLY A 192
None
1.13A19.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.78A80.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.08A21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.08A21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
5fur TRANSCRIPTION
INITIATION FACTOR
TFIID SUBUNIT 6
(Homo
sapiens)
4 / 6HIS J 422
ALA J 378
GLY J 375
TYR J 374
None
1.13A22.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.72A83.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.04A20.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.81A80.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.09A18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.06A21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.06A21.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.76A83.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
0.98A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
ALA A 610
GLY A 612
TYR A 613
None
0.29A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
None
0.84A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.10A18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.06A22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.04A22.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.84A81.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
4 / 4TRP A 174
HIS A 614
LYS A 617
MET A 618
None
0.22A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
0.98A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
ALA A 610
GLY A 612
TYR A 613
None
0.35A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
None
0.84A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4mob ACYL-COENZYME A
THIOESTERASE 12
(Homo
sapiens)
4 / 6ASN A 252
PHE A 285
ALA A 317
GLY A 316
ADP  A 402 (-2.9A)
ADP  A 402 (-4.8A)
None
None
1.14A17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4uis GAMMA-SECRETASE
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.13A19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.04A22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.04A22.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.84A81.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
2pfr ARYLAMINE
N-ACETYLTRANSFERASE
2
(Homo
sapiens)
3 / 3TRP A  67
HIS A  43
MET A  42
None
1.26A16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3b13 DEDICATOR OF
CYTOKINESIS PROTEIN
2
(Homo
sapiens)
3 / 3TRP A1481
HIS A1231
MET A1201
None
1.13A18.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
3 / 3TRP A 174
HIS A 614
MET A 618
None
0.27A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ff6 ACETYL-COA
CARBOXYLASE 2
(Homo
sapiens)
3 / 3TRP A2078
HIS A1993
MET A2075
None
1.07A21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4asi ACETYL-COA
CARBOXYLASE 1
(Homo
sapiens)
3 / 3TRP A2004
HIS A1919
MET A2001
None
1.09A22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5zbh NEUROPEPTIDE Y
RECEPTOR TYPE 1,T4
LYSOZYME,NEUROPEPTID
E Y RECEPTOR TYPE 1
(Escherichia
virus
T4;
Homo
sapiens)
3 / 3TRP A 276
HIS A 306
MET A 310
None
0.85A7.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5zbq NEUROPEPTIDE Y
RECEPTOR TYPE 1,T4
LYSOZYME
(Escherichia
virus
T4;
Homo
sapiens)
3 / 3TRP A 276
HIS A 306
MET A 310
None
1.04A6.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
0.99A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
ALA A 610
GLY A 612
TYR A 613
None
0.35A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
None
0.89A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.06A18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4mob ACYL-COENZYME A
THIOESTERASE 12
(Homo
sapiens)
4 / 6ASN A 252
PHE A 285
ALA A 317
GLY A 316
ADP  A 402 (-2.9A)
ADP  A 402 (-4.8A)
None
None
1.14A17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.03A22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.05A22.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.87A81.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1x6g MEGAKARYOCYTE-ASSOCI
ATED
TYROSINE-PROTEIN
KINASE
(Homo
sapiens)
3 / 3TRP A  53
HIS A  26
LYS A  30
None
1.45A7.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1xnj BIFUNCTIONAL
3'-PHOSPHOADENOSINE
5'-PHOSPHOSULFATE
SYNTHETASE 1
(Homo
sapiens)
3 / 3TRP B 457
HIS B 363
LYS B 367
None
1.30A22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
2qjf BIFUNCTIONAL
3'-PHOSPHOADENOSINE
5'-PHOSPHOSULFATE
SYNTHETASE 1
(Homo
sapiens)
3 / 3TRP A 457
HIS A 363
LYS A 367
None
1.08A20.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
3 / 3TRP A 174
HIS A 614
LYS A 617
None
0.25A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4b99 MITOGEN-ACTIVATED
PROTEIN KINASE 7
(Homo
sapiens)
3 / 3TRP A 226
HIS A 145
LYS A 184
None
1.33A18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4rws C-X-C CHEMOKINE
RECEPTOR TYPE
4/ENDOLYSIN CHIMERIC
PROTEIN
(Escherichia
virus
T4;
Homo
sapiens)
3 / 3TRP A 102
HIS A 113
LYS A 110
None
1.42A19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4wjg HAPTOGLOBIN
(Homo
sapiens)
3 / 3TRP C 280
HIS C 291
LYS C 293
None
1.41A15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4zrq CD320 ANTIGEN
TRANSCOBALAMIN-2
(Homo
sapiens)
3 / 3TRP C  72
HIS A  56
LYS A  59
None
1.48A8.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4zsl MITOGEN-ACTIVATED
PROTEIN KINASE 7
(Homo
sapiens)
3 / 3TRP A 226
HIS A 145
LYS A 184
GOL  A 406 (-3.7A)
None
None
1.36A16.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
3 / 3TRP A 174
HIS A 614
LYS A 617
None
0.44A81.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA864_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ixd TYROSINE-PROTEIN
KINASE JAK1
(Homo
sapiens)
3 / 3TRP A 116
HIS A 264
LYS A 267
None
1.48A20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.03A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
ALA A 610
GLY A 612
TYR A 613
None
0.39A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
5 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
None
0.90A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.09A18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4mob ACYL-COENZYME A
THIOESTERASE 12
(Homo
sapiens)
4 / 6ASN A 252
PHE A 285
ALA A 317
GLY A 316
ADP  A 402 (-2.9A)
ADP  A 402 (-4.8A)
None
None
1.13A17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.05A22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.04A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1433_1
(CHITINASE)
5l0v PROTEIN
O-GLUCOSYLTRANSFERAS
E 1
(Homo
sapiens)
4 / 5TRP A 164
TYR A 161
ASP A 133
PHE A 104
None
1.20A20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
1i71 APOLIPOPROTEIN(A)
(Homo
sapiens)
3 / 3TRP A  32
THR A  36
TYR A  39
None
0.84A8.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
1l1f GLUTAMATE
DEHYDROGENASE 1
(Homo
sapiens)
3 / 3TRP A 182
THR A 175
TYR A  99
None
0.70A19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2a5j RAS-RELATED PROTEIN
RAB-2B
(Homo
sapiens)
3 / 3TRP A 105
THR A  67
TYR A  80
None
1.02A17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2jgz G2/MITOTIC-SPECIFIC
CYCLIN-B1
(Homo
sapiens)
3 / 3TRP B 208
THR B 276
TYR B 277
None
0.80A21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2k60 PROTEIN (STROMAL
INTERACTION MOLECULE
1)
(Homo
sapiens)
3 / 3TRP A 132
THR A 143
TYR A 144
None
1.29A16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2mqi TYROSINE-PROTEIN
KINASE FYN
(Homo
sapiens)
3 / 3TRP A 149
THR A 223
TYR A 213
None
1.18A12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2n1b GTP-BINDING NUCLEAR
PROTEIN RAN
(Homo
sapiens)
3 / 3TRP A 104
THR A  66
TYR A  79
None
1.19A19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2o52 RAS-RELATED PROTEIN
RAB-4B
(Homo
sapiens)
3 / 3TRP A 102
THR A  64
TYR A  77
None
1.01A18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
2xyd ANGIOTENSIN-CONVERTI
NG ENZYME
(Homo
sapiens)
3 / 3TRP A 198
THR A 179
TYR A 175
None
1.23A23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
3f5x CYCLIN-A2
(Homo
sapiens)
3 / 3TRP B 217
THR B 285
TYR B 286
None
0.71A22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
3kv4 PHD FINGER PROTEIN 8
(Homo
sapiens)
3 / 3TRP A 282
THR A  82
TYR A 243
None
1.22A21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
3nbh RECQ-MEDIATED GENOME
INSTABILITY PROTEIN
1
RECQ-MEDIATED GENOME
INSTABILITY PROTEIN
2
(Homo
sapiens)
3 / 3TRP B  59
THR A 538
TYR A 493
None
1.24A17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
4bvw APOLIPOPROTEIN(A)
(Homo
sapiens)
3 / 3TRP A  32
THR A  36
TYR A  39
None
0.89A9.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
4lnp SORBIN AND SH3
DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)
3 / 3TRP A 830
THR A 845
TYR A 846
None
1.27A10.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
5f5r HEAT SHOCK PROTEIN
75 KDA,
MITOCHONDRIAL
(Homo
sapiens)
3 / 3TRP A 231
THR A  94
TYR A 206
None
1.29A21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
5fuc INTERLEUKIN-6
RECEPTOR SUBUNIT
ALPHA, INTERLEUKIN-6
RECEPTOR
(Homo
sapiens)
3 / 3TRP C 264
THR C 247
TYR C 238
None
1.29A17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
5mpo MOLYBDOPTERIN
SYNTHASE SULFUR
CARRIER SUBUNIT
(Homo
sapiens)
3 / 3TRP A  38
THR A  19
TYR A  11
None
1.29A15.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
5vem ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 5
(Homo
sapiens)
3 / 3TRP A 124
THR A  81
TYR A  77
None
1.16A20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1434_1
(CHITINASE)
5wp6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY M
MEMBER 4
(Homo
sapiens)
3 / 3TRP A 152
THR A 107
TYR A 103
None
1.00A12.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
1hjv CHITINASE-3 LIKE
PROTEIN 1
(Homo
sapiens)
7 / 11TYR A  27
PHE A  58
GLY A  98
MET A 204
TYR A 206
ASP A 207
TRP A 352
NAG  A  -1 (-3.8A)
NAG  A  -2 (-4.7A)
NAG  A  -2 ( 4.2A)
NAG  A   1 (-3.7A)
NAG  A  -1 (-4.6A)
NAG  A  -1 (-3.7A)
NAG  A  -1 (-3.5A)
0.66A30.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
8 / 11TYR A  27
PHE A  58
GLY A  98
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 358
AMI  A1388 (-3.6A)
AMI  A1388 (-4.8A)
AMI  A1388 ( 3.7A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
AMI  A1388 ( 2.9A)
NAA  A1387 (-3.6A)
AMI  A1388 (-3.5A)
0.74A30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
7 / 11PHE A  58
GLY A  98
ASP A 138
MET A 210
TYR A 212
TYR A 267
TRP A 360
None
0.84A30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
7 / 11TYR A  27
PHE A  58
GLY A  98
GLU A 140
MET A 210
TYR A 212
TRP A 360
None
0.82A30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
8 / 11TYR A  27
PHE A  58
GLY A  98
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
None
0.56A30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
7 / 11PHE A  58
GLY A  98
ASP A 138
MET A 210
TYR A 212
TYR A 267
TRP A 360
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.0A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
None
CX9  A1398 ( 3.3A)
0.84A31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
7 / 11TYR A  27
PHE A  58
GLY A  98
GLU A 140
MET A 210
TYR A 212
TRP A 360
None
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.7A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
CX9  A1398 ( 3.3A)
0.84A31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_A_CFFA1435_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
8 / 11TYR A  27
PHE A  58
GLY A  98
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
None
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
CX9  A1398 ( 4.4A)
None
CX9  A1398 ( 3.3A)
0.51A31.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
1bhg BETA-GLUCURONIDASE
(Homo
sapiens)
4 / 6GLU A 352
TYR A 388
ASP A 369
PHE A 589
None
1.36A23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
1w45 ANNEXIN A8
(Homo
sapiens)
4 / 6GLU A  28
ASP A  26
PHE A  21
ARG A  51
None
1.19A21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
3n9u CLEAVAGE AND
POLYADENYLATION
SPECIFICITY FACTOR
SUBUNIT 7
(Homo
sapiens)
4 / 6GLU C 153
ASP C 156
PHE C 168
ARG C 158
None
1.38A16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
3py7 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PAXILLIN
LD1,PROTEIN E6
CHIMERA
(Deltapapillomavi
rus
4;
Escherichia
coli;
Homo
sapiens)
4 / 6GLU A 311
TYR A 308
ASP A 315
ARG A 317
None
1.46A20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
4mzv EPITHELIAL CELL
ADHESION MOLECULE
(Homo
sapiens)
4 / 6GLU A 223
ASP A 219
PHE A 226
ARG A 173
None
None
None
DMU  A 301 (-4.0A)
1.46A17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
5fqd DNA DAMAGE-BINDING
PROTEIN 1
(Homo
sapiens)
4 / 6GLU A1095
ASP A1090
PHE A 998
ARG A1074
None
1.23A19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
5tj2 SUGAR ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN,GASDERMIN-B
FUSION PROTEIN
(Escherichia
coli;
Homo
sapiens)
4 / 6GLU A 310
TYR A 307
ASP A 314
ARG A 316
None
1.48A21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
5vcs ALPHA-1,6-MANNOSYL-G
LYCOPROTEIN
2-BETA-N-ACETYLGLUCO
SAMINYLTRANSFERASE
(Homo
sapiens)
4 / 6TYR A 443
ASP A 436
PHE A 188
ARG A 223
None
1.14A12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2434_1
(CHITINASE)
6cnj NEURONAL
ACETYLCHOLINE
RECEPTOR SUBUNIT
BETA-2
(Homo
sapiens)
4 / 6GLU B 133
ASP B 140
PHE B 137
ARG B 207
None
1.48A11.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1hjv CHITINASE-3 LIKE
PROTEIN 1
(Homo
sapiens)
6 / 10PHE A  58
GLY A  98
MET A 204
TYR A 206
ASP A 207
TRP A 352
NAG  A  -2 (-4.7A)
NAG  A  -2 ( 4.2A)
NAG  A   1 (-3.7A)
NAG  A  -1 (-4.6A)
NAG  A  -1 (-3.7A)
NAG  A  -1 (-3.5A)
0.51A30.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
6 / 10PHE A  58
ASP A 138
GLU A 140
MET A 210
TYR A 212
TRP A 358
AMI  A1388 (-4.8A)
AMI  A1388 (-3.1A)
AMI  A1388 ( 3.3A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
AMI  A1388 (-3.5A)
1.10A30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
6 / 10PHE A  58
ASP A 138
MET A 210
TYR A 212
TYR A 267
TRP A 358
AMI  A1388 (-4.8A)
AMI  A1388 (-3.1A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
NAA  A1387 (-3.6A)
AMI  A1388 (-3.5A)
0.97A30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
6 / 10PHE A  58
GLY A  98
GLU A 140
MET A 210
TYR A 212
TRP A 358
AMI  A1388 (-4.8A)
AMI  A1388 ( 3.7A)
AMI  A1388 ( 3.3A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
AMI  A1388 (-3.5A)
0.78A30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 358
AMI  A1388 (-4.8A)
AMI  A1388 ( 3.7A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
AMI  A1388 ( 2.9A)
NAA  A1387 (-3.6A)
AMI  A1388 (-3.5A)
0.48A30.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
ASP A 138
GLU A 140
MET A 210
TYR A 212
TRP A 360
None
0.98A30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
ASP A 138
MET A 210
TYR A 212
TYR A 267
TRP A 360
None
0.81A30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
None
0.37A30.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
ASP A 138
GLU A 140
MET A 210
TYR A 212
TRP A 360
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.0A)
CX9  A1398 (-3.7A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
CX9  A1398 ( 3.3A)
1.01A31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
ASP A 138
MET A 210
TYR A 212
TYR A 267
TRP A 360
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.0A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
None
CX9  A1398 ( 3.3A)
0.81A31.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2A3B_B_CFFB2435_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
7 / 10PHE A  58
GLY A  98
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
CX9  A1398 ( 4.4A)
None
CX9  A1398 ( 3.3A)
0.32A31.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2435_1
(CHITINASE)
4ay1 CHITINASE-3-LIKE
PROTEIN 2
(Homo
sapiens)
5 / 10PHE A  63
GLY A 103
ASP A 213
TYR A 269
TRP A 360
None
NAG  A 401 (-3.5A)
NAG  A 401 (-2.8A)
NAG  A 400 (-3.7A)
NAG  A 401 (-3.7A)
0.59A28.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.01A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.86A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.12A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4uis GAMMA-SECRETASE
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.13A19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.07A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.03A22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.77A81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.02A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.86A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.09A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.06A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.07A22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.81A81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5syt CAAX PRENYL PROTEASE
1 HOMOLOG
(Homo
sapiens)
4 / 6PHE A 108
ALA A 112
GLY A 110
TYR A 111
None
1.14A21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.00A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.88A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.11A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4uis GAMMA-SECRETASE
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.12A19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.06A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.03A22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fur TRANSCRIPTION
INITIATION FACTOR
TFIID SUBUNIT 6
(Homo
sapiens)
4 / 6HIS J 422
ALA J 378
GLY J 375
TYR J 374
None
1.14A20.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.82A81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.00A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.87A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.09A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4mob ACYL-COENZYME A
THIOESTERASE 12
(Homo
sapiens)
4 / 6ASN A 252
PHE A 285
ALA A 317
GLY A 316
ADP  A 402 (-2.9A)
ADP  A 402 (-4.8A)
None
None
1.13A17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4uis GAMMA-SECRETASE
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.14A19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.04A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.04A22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.79A81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
0.99A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.88A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.12A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4uis GAMMA-SECRETASE
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.12A19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.08A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.02A22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.83A81.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
1zef ALKALINE PHOSPHATASE
(Homo
sapiens)
4 / 6ASN A  84
PHE A 107
ALA A  94
GLY A  93
None
PHE  A 802 (-4.4A)
None
SEP  A  92 ( 2.4A)
1.00A21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3cem GLYCOGEN
PHOSPHORYLASE, LIVER
FORM
(Homo
sapiens)
6 / 6ASN A 282
PHE A 285
HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.89A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
3ldo 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.11A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
4uis GAMMA-SECRETASE
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.15A19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN
(Homo
sapiens)
4 / 6ASN A 177
PHE A 176
ALA A 179
GLY A 100
None
1.06A22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5fn4 NICASTRIN
(Homo
sapiens)
4 / 6PHE A 448
HIS A 449
ALA A 442
GLY A 366
None
1.05A22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)
5ikp GLYCOGEN
PHOSPHORYLASE, BRAIN
FORM
(Homo
sapiens)
4 / 6HIS A 571
ALA A 610
GLY A 612
TYR A 613
None
0.82A81.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1hjv CHITINASE-3 LIKE
PROTEIN 1
(Homo
sapiens)
7 / 11PHE A  58
GLY A  98
TRP A  99
MET A 204
TYR A 206
ASP A 207
TRP A 352
NAG  A  -2 (-4.7A)
NAG  A  -2 ( 4.2A)
NAG  A   1 (-3.6A)
NAG  A   1 (-3.7A)
NAG  A  -1 (-4.6A)
NAG  A  -1 (-3.7A)
NAG  A  -1 (-3.5A)
0.73A30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1hjv CHITINASE-3 LIKE
PROTEIN 1
(Homo
sapiens)
7 / 11TYR A  27
PHE A  58
GLY A  98
MET A 204
TYR A 206
ASP A 207
TRP A 352
NAG  A  -1 (-3.8A)
NAG  A  -2 (-4.7A)
NAG  A  -2 ( 4.2A)
NAG  A   1 (-3.7A)
NAG  A  -1 (-4.6A)
NAG  A  -1 (-3.7A)
NAG  A  -1 (-3.5A)
0.74A30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
9 / 11PHE A  58
GLY A  98
TRP A  99
GLU A 140
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 358
AMI  A1388 (-4.8A)
AMI  A1388 ( 3.7A)
NAA  A1390 ( 4.3A)
AMI  A1388 ( 3.3A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
AMI  A1388 ( 2.9A)
NAA  A1387 (-3.6A)
AMI  A1388 (-3.5A)
0.72A33.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
9 / 11TYR A  27
PHE A  58
GLY A  98
GLU A 140
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 358
AMI  A1388 (-3.6A)
AMI  A1388 (-4.8A)
AMI  A1388 ( 3.7A)
AMI  A1388 ( 3.3A)
AMI  A1388 (-3.3A)
AMI  A1388 (-4.8A)
AMI  A1388 ( 2.9A)
NAA  A1387 (-3.6A)
AMI  A1388 (-3.5A)
0.79A33.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
8 / 11PHE A  58
GLY A  98
TRP A  99
GLU A 140
MET A 210
ASP A 213
TYR A 267
TRP A 360
None
0.78A30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
8 / 11TYR A  27
PHE A  58
GLY A  98
ASP A 138
MET A 210
TYR A 212
TYR A 267
TRP A 360
None
0.94A30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
9 / 11TYR A  27
PHE A  58
GLY A  98
GLU A 140
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
None
0.64A30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
9 / 11PHE A  58
GLY A  98
TRP A  99
GLU A 140
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1399 ( 3.4A)
CX9  A1398 (-3.7A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
CX9  A1398 ( 4.4A)
None
CX9  A1398 ( 3.3A)
0.63A30.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
6 / 11TYR A  27
PHE A  58
GLY A  98
ASP A 138
TYR A 212
TYR A 267
None
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.0A)
CX9  A1398 (-4.3A)
None
1.00A30.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA1_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
9 / 11TYR A  27
PHE A  58
GLY A  98
GLU A 140
MET A 210
TYR A 212
ASP A 213
TYR A 267
TRP A 360
None
CX9  A1398 (-4.5A)
CX9  A1398 (-3.5A)
CX9  A1398 (-3.7A)
CX9  A1398 (-3.3A)
CX9  A1398 (-4.3A)
CX9  A1398 ( 4.4A)
None
CX9  A1398 ( 3.3A)
0.59A30.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G6M_A_CFFA1_1
(CHITINASE)
3bxw CHITINASE
DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)
6 / 11TYR B  62
GLU B 170
MET B 237
TYR B 239
TYR B 280
TRP B 358
None
0.99A23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G6M_A_CFFA1_1
(CHITINASE)
4ay1 CHITINASE-3-LIKE
PROTEIN 2
(Homo
sapiens)
6 / 11TYR A  32
PHE A  63
GLY A 103
ASP A 213
TYR A 269
TRP A 360
NAG  A 401 (-3.9A)
None
NAG  A 401 (-3.5A)
NAG  A 401 (-2.8A)
NAG  A 400 (-3.7A)
NAG  A 401 (-3.7A)
0.80A27.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA427_1
(CHITINASE)
1hjv CHITINASE-3 LIKE
PROTEIN 1
(Homo
sapiens)
4 / 5TRP A  99
TYR A 141
MET A 204
ASP A 207
NAG  A   1 (-3.6A)
NAG  A   1 (-4.9A)
NAG  A   1 (-3.7A)
NAG  A  -1 (-3.7A)
0.74A30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA427_1
(CHITINASE)
1hkk CHITOTRIOSIDASE-1
(Homo
sapiens)
5 / 5TRP A  99
TYR A 141
MET A 210
ASP A 213
TRP A 218
NAA  A1390 ( 4.3A)
NAA  A1390 (-4.5A)
AMI  A1388 (-3.3A)
AMI  A1388 ( 2.9A)
NAA  A1390 (-3.2A)
0.84A33.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA427_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
4 / 5TRP A  99
TYR A 141
MET A 210
ASP A 213
None
0.91A30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA427_1
(CHITINASE)
1wb0 CHITOTRIOSIDASE 1
(Homo
sapiens)
4 / 5TYR A 141
MET A 210
ASP A 213
TRP A 218
None
0.55A30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G6M_A_CFFA427_1
(CHITINASE)
2ybu ACIDIC MAMMALIAN
CHITINASE
(Homo
sapiens)
5 / 5TRP A  99
TYR A 141
MET A 210
ASP A 213
TRP A 218
CX9  A1399 ( 3.4A)
None
CX9  A1398 (-3.3A)
CX9  A1398 ( 4.4A)
CX9  A1399 (-3.3A)
0.73A30.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
1vd2 PROTEIN KINASE C,
IOTA TYPE
(Homo
sapiens)
4 / 7VAL A  19
MET A  59
LEU A  77
ILE A  36
None
0.89A15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
2b4x ANTITHROMBIN-III
(Homo
sapiens)
4 / 7VAL I 165
LEU I  51
ASN I  55
ILE I 119
None
1.02A20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
2ibu ACETYL-COA
ACETYLTRANSFERASE
(Homo
sapiens)
4 / 7PHE A 315
MET A 141
LEU A 295
ILE A 133
None
1.02A23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
2qp4 BILE SALT
SULFOTRANSFERASE
(Homo
sapiens)
4 / 7PHE A 109
MET A 173
LEU A  40
ILE A  38
None
0.72A17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
2rvj EPITHELIAL SPLICING
REGULATORY PROTEIN 1
(Homo
sapiens)
4 / 7VAL A 520
MET A 513
LEU A 465
ILE A 493
None
0.90A15.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
3qak ADENOSINE RECEPTOR
A2A,LYSOZYME CHIMERA
(Escherichia
virus
T4;
Homo
sapiens)
6 / 7VAL A  84
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
None
UKA  A1200 (-3.4A)
UKA  A1200 (-4.8A)
UKA  A1200 (-4.9A)
UKA  A1200 (-3.4A)
UKA  A1200 (-4.9A)
1.00A65.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
4at3 BDNF/NT-3 GROWTH
FACTORS RECEPTOR
(Homo
sapiens)
4 / 7VAL A 706
LEU A 645
ASN A 642
ILE A 762
None
1.01A19.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5g53 ADENOSINE RECEPTOR
A2A
(Homo
sapiens)
5 / 7MET A 174
LEU A 249
ASN A 253
MET A 270
ILE A 274
NEC  A 400 ( 4.8A)
NEC  A 400 ( 4.6A)
NEC  A 400 (-3.3A)
None
NEC  A 400 (-4.6A)
1.44A91.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5g53 ADENOSINE RECEPTOR
A2A
(Homo
sapiens)
6 / 7VAL A  84
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
None
NEC  A 400 (-3.6A)
NEC  A 400 (-4.8A)
NEC  A 400 ( 4.6A)
NEC  A 400 (-3.3A)
NEC  A 400 (-4.6A)
1.04A91.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5lzk PROTEIN FAM83B
(Homo
sapiens)
4 / 7VAL A 199
MET A 191
LEU A 180
ILE A 178
None
1.03A20.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1
(Escherichia
coli;
Homo
sapiens)
5 / 7VAL A1192
PHE A1276
LEU A1355
ASN A1359
ILE A1379
8K8  A2001 ( 4.1A)
8K8  A2001 ( 3.4A)
8K8  A2001 ( 4.3A)
8K8  A2001 ( 3.1A)
8K8  A2001 ( 4.2A)
0.87A45.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1
(Escherichia
coli;
Homo
sapiens)
5 / 7VAL A1192
PHE A1276
MET A1285
LEU A1355
ASN A1359
8K8  A2001 ( 4.1A)
8K8  A2001 ( 3.4A)
8K8  A2001 ( 4.5A)
8K8  A2001 ( 4.3A)
8K8  A2001 ( 3.1A)
0.89A45.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5nug CYTOPLASMIC DYNEIN 1
HEAVY CHAIN 1
(Homo
sapiens)
4 / 7MET A2755
LEU A2769
ASN A2752
MET A2773
None
0.67A5.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1
(Escherichia
coli;
Homo
sapiens)
6 / 7VAL A  87
PHE A 171
MET A 180
LEU A 250
ASN A 254
ILE A 274
DU1  A1201 (-4.7A)
DU1  A1201 (-3.5A)
DU1  A1201 (-3.4A)
DU1  A1201 (-4.4A)
DU1  A1201 (-3.1A)
DU1  A1201 (-4.3A)
0.94A40.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
5v57 SMOOTHENED
HOMOLOG,FLAVODOXIN,S
MOOTHENED HOMOLOG
(Desulfovibrio
vulgaris;
Homo
sapiens)
4 / 7VAL A 321
LEU A 522
MET A 230
ILE A 234
None
836  A1201 (-4.6A)
836  A1201 (-3.5A)
None
0.87A21.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
6aqf ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A
(Escherichia
coli;
Homo
sapiens)
5 / 7PHE A 168
LEU A 249
ASN A 253
MET A 270
ILE A 274
ZMA  A1201 (-3.5A)
ZMA  A1201 (-4.1A)
ZMA  A1201 (-3.2A)
ZMA  A1201 (-4.8A)
ZMA  A1201 (-4.8A)
0.69A86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
6aqf ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A
(Escherichia
coli;
Homo
sapiens)
6 / 7VAL A  84
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
None
ZMA  A1201 (-3.5A)
None
ZMA  A1201 (-4.1A)
ZMA  A1201 (-3.2A)
ZMA  A1201 (-4.8A)
0.62A86.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
6d9h CHIMERA PROTEIN OF
MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4 AND
ADENOSINE RECEPTOR
A1
(Homo
sapiens)
6 / 7VAL R  87
PHE R 171
MET R 180
LEU R 250
ASN R 254
ILE R 274
ADN  R 400 (-4.8A)
ADN  R 400 (-3.8A)
ADN  R 400 (-4.6A)
ADN  R 400 (-4.5A)
ADN  R 400 (-2.9A)
ADN  R 400 ( 4.9A)
1.04A15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
6gdg TRXA,ADENOSINE
RECEPTOR A2A
(Escherichia
coli;
Homo
sapiens)
5 / 7MET A 174
LEU A 249
ASN A 253
MET A 270
ILE A 274
NEC  A 400 ( 4.7A)
NEC  A 400 (-4.9A)
NEC  A 400 (-3.5A)
None
NEC  A 400 (-4.2A)
1.40A13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RFM_A_CFFA330_1
(ADENOSINE RECEPTOR
A2A)
6gdg TRXA,ADENOSINE
RECEPTOR A2A
(Escherichia
coli;
Homo
sapiens)
4 / 7MET A 177
LEU A 249
ASN A 253
ILE A 274
NEC  A 400 (-4.3A)
NEC  A 400 (-4.9A)
NEC  A 400 (-3.5A)
NEC  A 400 (-4.2A)
0.65A13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
1wyo MICROTUBULE-ASSOCIAT
ED PROTEIN RP/EB
FAMILY MEMBER 3
(Homo
sapiens)
4 / 6LEU A  58
PHE A 122
ILE A 115
PHE A 118
None
1.13A21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
1ya0 SMG-7 TRANSCRIPT
VARIANT 2
(Homo
sapiens)
4 / 6LEU A 272
LEU A 334
ILE A 254
PHE A 253
None
0.97A20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
2d5r CCR4-NOT
TRANSCRIPTION
COMPLEX SUBUNIT 7
(Homo
sapiens)
4 / 6ASP A  70
LEU A  65
ILE A 184
PHE A 181
None
1.06A19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
2jak SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens)
4 / 6LEU A 224
LEU A 254
PHE A 208
PHE A 211
None
1.06A21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
3nh9 ATP-BINDING CASSETTE
SUB-FAMILY B MEMBER
6, MITOCHONDRIAL
(Homo
sapiens)
4 / 6LEU A 795
LEU A 606
ILE A 590
PHE A 592
None
1.16A22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
4gmj CCR4-NOT
TRANSCRIPTION
COMPLEX SUBUNIT 7
(Homo
sapiens)
4 / 6ASP B  70
LEU B  65
ILE B 184
PHE B 181
None
0.95A18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
5e26 PANTOTHENATE KINASE
2, MITOCHONDRIAL
(Homo
sapiens)
4 / 6LEU A 524
LEU A 435
ILE A 497
PHE A 418
None
1.04A22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
5h64 SERINE/THREONINE-PRO
TEIN KINASE MTOR
(Homo
sapiens)
4 / 6LEU A1142
ASP A1147
LEU A1115
ILE A1156
None
1.20A8.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
5hcc COMPLEMENT C5
(Homo
sapiens)
4 / 6ASP A1330
LEU A 982
PHE A1333
ILE A1313
None
1.17A16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
5tfm CADHERIN-23
(Homo
sapiens)
4 / 6LEU A 817
LEU A 829
PHE A 800
ILE A 810
None
1.19A14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
5y3r X-RAY REPAIR
CROSS-COMPLEMENTING
PROTEIN 6
(Homo
sapiens)
4 / 6LEU A  38
ASP A  81
LEU A 108
ILE A  67
None
1.13A18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
6bfn INTERLEUKIN-1
RECEPTOR-ASSOCIATED
KINASE 1
(Homo
sapiens)
4 / 6LEU A 501
LEU A 496
ILE A 341
PHE A 410
None
1.25A15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
6d9h CHIMERA PROTEIN OF
MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4 AND
ADENOSINE RECEPTOR
A1
(Homo
sapiens)
4 / 6LEU R  29
PHE R 299
ILE R 292
PHE R 295
None
0.93A13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
6fra HUMAN T-CELL
RECEPTOR F11 ALPHA
CHAIN
(Homo
sapiens)
4 / 6LEU A  44
PHE A  90
ILE A 101
PHE A 102
EDO  A 304 (-4.9A)
None
None
EDO  A 306 ( 4.1A)
1.26A14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
2qp4 BILE SALT
SULFOTRANSFERASE
(Homo
sapiens)
5 / 9ILE A  32
PHE A 109
MET A 173
LEU A  40
ILE A  38
None
1.12A19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
3gd7 FUSION COMPLEX OF
CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR, RESIDUES
1193-1427 AND
MALTOSE/MALTODEXTRIN
IMPORT ATP-BINDING
PROTEIN MALK,
RESIDUES 219-371
(Escherichia
coli;
Homo
sapiens)
5 / 9ILE A1554
VAL A1507
MET A1469
LEU A1451
ILE A1494
None
1.41A21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
3gd7 FUSION COMPLEX OF
CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR, RESIDUES
1193-1427 AND
MALTOSE/MALTODEXTRIN
IMPORT ATP-BINDING
PROTEIN MALK,
RESIDUES 219-371
(Escherichia
coli;
Homo
sapiens)
5 / 9ILE A1554
VAL A1507
MET A1469
LEU A1492
ILE A1494
None
1.15A21.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
3qak ADENOSINE RECEPTOR
A2A,LYSOZYME CHIMERA
(Escherichia
virus
T4;
Homo
sapiens)
6 / 9ILE A  66
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
UKA  A1200 (-4.1A)
UKA  A1200 (-3.4A)
UKA  A1200 (-4.8A)
UKA  A1200 (-4.9A)
UKA  A1200 (-3.4A)
UKA  A1200 (-4.9A)
0.46A69.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
3qak ADENOSINE RECEPTOR
A2A,LYSOZYME CHIMERA
(Escherichia
virus
T4;
Homo
sapiens)
6 / 9VAL A  84
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
None
UKA  A1200 (-3.4A)
UKA  A1200 (-4.8A)
UKA  A1200 (-4.9A)
UKA  A1200 (-3.4A)
UKA  A1200 (-4.9A)
0.86A69.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
5g53 ADENOSINE RECEPTOR
A2A
(Homo
sapiens)
8 / 9ILE A  66
PHE A 168
GLU A 169
MET A 177
LEU A 249
ASN A 253
MET A 270
ILE A 274
None
NEC  A 400 (-3.6A)
NEC  A 400 (-4.0A)
NEC  A 400 (-4.8A)
NEC  A 400 ( 4.6A)
NEC  A 400 (-3.3A)
None
NEC  A 400 (-4.6A)
0.48A70.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
5g53 ADENOSINE RECEPTOR
A2A
(Homo
sapiens)
8 / 9VAL A  84
PHE A 168
GLU A 169
MET A 177
LEU A 249
ASN A 253
MET A 270
ILE A 274
None
NEC  A 400 (-3.6A)
NEC  A 400 (-4.0A)
NEC  A 400 (-4.8A)
NEC  A 400 ( 4.6A)
NEC  A 400 (-3.3A)
None
NEC  A 400 (-4.6A)
0.82A70.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1
(Escherichia
coli;
Homo
sapiens)
7 / 9ILE A1174
VAL A1192
PHE A1276
MET A1285
LEU A1355
ASN A1359
ILE A1379
8K8  A2001 ( 4.0A)
8K8  A2001 ( 4.1A)
8K8  A2001 ( 3.4A)
8K8  A2001 ( 4.5A)
8K8  A2001 ( 4.3A)
8K8  A2001 ( 3.1A)
8K8  A2001 ( 4.2A)
0.73A37.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1
(Escherichia
coli;
Homo
sapiens)
6 / 9VAL A  87
PHE A 171
MET A 180
LEU A 250
ASN A 254
ILE A 274
DU1  A1201 (-4.7A)
DU1  A1201 (-3.5A)
DU1  A1201 (-3.4A)
DU1  A1201 (-4.4A)
DU1  A1201 (-3.1A)
DU1  A1201 (-4.3A)
0.58A64.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
6aqf ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A
(Escherichia
coli;
Homo
sapiens)
9 / 9ILE A  66
VAL A  84
PHE A 168
GLU A 169
MET A 177
LEU A 249
ASN A 253
MET A 270
ILE A 274
None
None
ZMA  A1201 (-3.5A)
ZMA  A1201 (-4.1A)
None
ZMA  A1201 (-4.1A)
ZMA  A1201 (-3.2A)
ZMA  A1201 (-4.8A)
ZMA  A1201 (-4.8A)
0.32A98.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
6d9h CHIMERA PROTEIN OF
MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4 AND
ADENOSINE RECEPTOR
A1
(Homo
sapiens)
7 / 9ILE R  69
VAL R  87
PHE R 171
MET R 180
LEU R 250
ASN R 254
ILE R 274
None
ADN  R 400 (-4.8A)
ADN  R 400 (-3.8A)
ADN  R 400 (-4.6A)
ADN  R 400 (-4.5A)
ADN  R 400 (-2.9A)
ADN  R 400 ( 4.9A)
0.97A11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
6d9h CHIMERA PROTEIN OF
MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4 AND
ADENOSINE RECEPTOR
A1
(Homo
sapiens)
5 / 9PHE R 171
GLU R 172
MET R 180
LEU R 250
ASN R 254
ADN  R 400 (-3.8A)
ADN  R 400 (-3.5A)
ADN  R 400 (-4.6A)
ADN  R 400 (-4.5A)
ADN  R 400 (-2.9A)
1.02A11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
6gdg TRXA,ADENOSINE
RECEPTOR A2A
(Escherichia
coli;
Homo
sapiens)
6 / 9ILE A  66
MET A 177
LEU A 249
ASN A 253
MET A 270
ILE A 274
None
NEC  A 400 (-4.3A)
NEC  A 400 (-4.9A)
NEC  A 400 (-3.5A)
None
NEC  A 400 (-4.2A)
0.41A12.87